Revenio Group Corporation Announces Appointments in Management Team, Effective February 1, 2018
January 24, 2018 at 02:00 am EST
Share
As of February 1, 2018, QA Manager, M.Sc., Heli Valtanen and R&D Director, M.Sc. Mika Salkola from Icare Finland Ltd. will be appointed as members of Revenio Group's Management Team. Valtanen will also be appointed as QA Director to Revenio Group and Mika Salkola will be appointed as R&D Director to Revenio Research Oy, as the current position holder, M.Sc. (Tech) Ari Kukkonen will move to part-time retirement. Ari Kukkonen continues as Senior Advisor and member of Extended Management Team at Revenio Group. Heli Valtanen has held the position of QA Manager at Icare Finland since 2010. Previously Heli has worked as QA Manager at Plexpress Oy, as CTO at CTT Cancer Targeting Technologies Ltd. and as Research Scientist at University of Helsinki, Haartman Institute. Mika Salkola has worked as R&D Director of Icare Finland since September 2015. Mika has extensive experience in R&D. He has over 20 years of experience in international R&D operations, among others at Thermo Fisher Scientific and Vaisala.
Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company primarily engaged in the health technology segment. The Companyâs activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material handling systems. It distributes products in a range of countries, including the United States, Canada, Australia, Japan and India. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.
REVENIO GROUP OYJ 
